APA (7th ed.) Citation

WR, L., WQ, L., TAH, A., RB, C., HP, L., J, D., & J, Y. (2026). Magrolimab (Hu5F9-G4) promotes macrophage M1 polarization and is associated with enhanced autophagy in colorectal cancer. Translational oncology, 63, 102598. https://doi.org/10.1016/j.tranon.2025.102598

Chicago Style (17th ed.) Citation

WR, Lin, Liu WQ, Alburiahi TAH, Chen RB, Lu HP, Dong J, and Yang J. "Magrolimab (Hu5F9-G4) Promotes Macrophage M1 Polarization and Is Associated with Enhanced Autophagy in Colorectal Cancer." Translational Oncology 63 (2026): 102598. https://doi.org/10.1016/j.tranon.2025.102598.

MLA (9th ed.) Citation

WR, Lin, et al. "Magrolimab (Hu5F9-G4) Promotes Macrophage M1 Polarization and Is Associated with Enhanced Autophagy in Colorectal Cancer." Translational Oncology, vol. 63, 2026, p. 102598, https://doi.org/10.1016/j.tranon.2025.102598.